AU

Anand Uppal

Active Director Director DIN 01258893
DIN 01258893 First appointment Mar 2004 Primary industry Media and Publishing
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 2 historical roles
Total affiliations 7 Since Mar 2004
Shareholding value •••• Premium profile

About Anand Uppal

Data last updated:

Anand Uppal is a Director at Chemzin Graphics Private Limited (since 2020), Director at Ulabs Private Limited (since 2020) and Director at Biotrendz Medicament Private Limited (since 2020), and holds 2 more current directorships. The companies operate in Media and Publishing, Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹7.67 Cr; the largest is Chemzin Graphics Private Limited at ₹7.59 Cr (FY 2025). Earlier, Anand Uppal was a Director at Chemzin Labs Private Limited (from 2020) and Director at Uv Softech Private Limited (from 2004).

DIN 01258893
Primary Designation Director
Industry Media and Publishing
First Appointment 11 Mar 2004
Oldest Company Age 38 yrs
Largest company Chemzin Graphics Private Limited · ₹7.59 Cr (FY 2025)
Combined revenue ₹7.67 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chemzin Graphics Private Limited U21099CH2020PTC043141
Director18 Aug 20202020₹7.59 Cr (FY 2025)Active
Ulabs Private Limited U24230CH2020PTC043122
Director31 Jul 20202020₹7.5 Lakh (FY 2024)Active
Biotrendz Medicament Private Limited U24304CH2020PTC042885
Director24 Jan 20202020Active
Director30 Aug 20232023Active
Vadsp Pharma Care Private Limited U24232CH1988PTC008335
Director24 Nov 20041988Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chemzin Labs Private Limited U24297CH2020PTC043132
Director03 Aug 20202020Strike Off
Uv Softech Private Limited U99999CH2004PTC026907
Director11 Mar 20042004Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Anand Uppal

Directorship timeline

Open interactive timeline →
Ulabs Private Limited
Vadsp Pharma Care Private Limited
Chemzin Labs Private Limited
Biotrendz Medicament Private Limited
Premium access

Shareholding and investment profile for Anand Uppal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anand Uppal

Anand Uppal currently holds 5 directorships: Chemzin Graphics Private Limited (Director, since 18 Aug 2020, revenue ₹7.59 Cr (FY 2025)); Ulabs Private Limited (Director, since 31 Jul 2020, revenue ₹7.5 Lakh (FY 2024)); Biotrendz Medicament Private Limited (Director, since 24 Jan 2020); Chemzin Biotox Research Institute Private Limited (Director, since 30 Aug 2023); Vadsp Pharma Care Private Limited (Director, since 24 Nov 2004).

Anand Uppal was first appointed on 11 Mar 2004 as Director at Uv Softech Private Limited. The most recent appointment on record is 30 Aug 2023 at Chemzin Biotox Research Institute Private Limited.

The 2 current companies of Anand Uppal that report revenue have a combined latest revenue of ₹7.67 Cr: Chemzin Graphics Private Limited ₹7.59 Cr (FY 2025); Ulabs Private Limited ₹7.5 Lakh (FY 2024).

Anand Uppal held 2 earlier board appointments: Chemzin Labs Private Limited (Director, from 03 Aug 2020); Uv Softech Private Limited (Director, from 11 Mar 2004).

The current boards of Anand Uppal's companies include Vijay Kumar Uppal (Chemzin Graphics Private Limited), Keshav Kumar (Biotrendz Medicament Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available